BeOne Medicines
ONC
#638
Rank
C$51.13 B
Marketcap
C$462.12
Share price
-1.91%
Change (1 day)
64.94%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Operating Margin for BeOne Medicines (ONC)

Operating Margin as of December 2025 (TTM): 3.67%

According to BeOne Medicines's latest financial reports and stock price the company's current Operating Margin is 3.67%. At the end of 2024 the company had an Operating Margin of -13.99%.

Operating Margin history for BeOne Medicines from 2015 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-13.99%-58.35%
2023-33.59%-75.75%
2022-138.50%13.25%
2021-122.30%-76.66%
2020-523.90%137.75%
2019-220.35%-36.68%
2018-348.01%811.02%
2017-38.20%-99.66%
2016-11,136.73%1619.4%
2015-647.71%355.24%
2014-142.28%100.93%
2013-70.81%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Onconova Therapeutics
ONTX
-8,391.15%-228,741.69%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-24.83%-776.57%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.